Market Tracker

03/26 5:45pm ET

Neurocrine Biosciences Inc (NASDAQ:NBIX)

37.33
Delayed Data
As of Mar 26
 +0.96 / +2.64%
Today’s Change
12.17
Today|||52-Week Range
45.36
+67.10%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close36.37
Today’s open35.61
Day’s range-- - --
Volume1,717,314
Average volume (3 months)1,312,735
Market cap$3.1B
Dividend yield--
Data as of 03/26/2015

Growth & Valuation

Earnings growth (last year)-17.39%
Earnings growth (this year)-26.81%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book13.33

Competitors

 Today’s
change
Today’s
% change
ACADACADIA Pharmaceutica...-0.83-2.66%
IPXLImpax Laboratories I...+0.42+0.94%
HZNPHorizon Pharma PLC+0.53+2.55%
MYGNMyriad Genetics Inc-0.65-1.78%
Data as of 3:59pm ET, 03/26/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$0.00
Annual profit (last year)-$60.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin Charles Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts